Amundi
EXAS

Amundi’s Exact Sciences EXAS Stock Holding History

Amundi’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-56,381
Closed -$5.73M – 2059
2025
Q4 		$5.73M Sell
56,381
-641,251
-92% -$51.5M ﹤0.01% 1008
2025
Q3 		$40.2M Buy
697,632
+71,503
+11% +$3.57M 0.01% 608
2025
Q2 		$33.7M Sell
626,129
-147,842
-19% -$7.51M 0.01% 627
2025
Q1 		$34.3M Buy
773,971
+631,378
+443% +$32M 0.01% 607
2024
Q4 		$8.08M Buy
142,593
+1,592
+1% +$99.1K ﹤0.01% 899
2024
Q3 		$9.67M Sell
141,001
-15,035
-10% -$849K ﹤0.01% 850
2024
Q2 		$6.74M Sell
156,036
-601
-0.4% -$33.1K ﹤0.01% 913
2024
Q1 		$9.94M Sell
156,637
-34,082
-18% -$2.16M ﹤0.01% 840
2023
Q4 		$13.3M Sell
190,719
-36,873
-16% -$2.42M 0.01% 790
2023
Q3 		$14.9M Buy
227,592
+29,536
+15% +$2.51M 0.01% 753
2023
Q2 		$18.5M Buy
198,056
+59,815
+43% +$4.67M 0.01% 704
2023
Q1 		$8.91M Sell
138,241
-77,162
-36% -$4.96M ﹤0.01% 864
2022
Q4 		$14.5M Sell
215,403
-162,503
-43% -$6.64M 0.01% 773
2022
Q3 		$13.6M Sell
377,906
-868,500
-70% -$35.8M 0.01% 773
2022
Q2 		$57.4M Sell
1,246,406
-69,690
-5% -$3.73M 0.05% 410
2022
Q1 		$90.2M Sell
1,316,096
-860,298
-40% -$62.9M 0.06% 316
2021
Q4 		$164M Buy
2,176,394
+296,918
+16% +$26.2M 0.1% 217
2021
Q3 		$179M Buy
1,879,476
+215,060
+13% +$22.7M 0.13% 192
2021
Q2 		$207M Buy
+1,664,416
New +$199M 0.14% 169

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Amundi's EXAS Position: Q1 2026 in Review

Amundi sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 56,381 shares — an estimated $5.73M sold.

Amundi first reported a position in EXAS in Q2 2021 and held it in 19 quarters. The position peaked at $207M in Q2 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Amundi reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Amundi sold 56,381 Exact Sciences shares in Q1 2026, an estimated $5.73M.
  • Amundi first reported a position in Exact Sciences in Q2 2021 and held it in 19 quarters.
  • Amundi's Exact Sciences position peaked at $207M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.